Sphera Funds Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Sphera Funds Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,411	Closed	-$969K	–	94
2021 Q4	$969K	Buy	+4,411	New	+$858K	0.11%	86
2021 Q2	–	Sell	-5,530	Closed	-$1.19M	–	169
2021 Q1	$1.19M	Buy	+5,530	New	+$1.21M	0.09%	136
2020 Q2	–	Sell	-7,000	Closed	-$1.67M	–	108
2020 Q1	$1.67M	Buy	+7,000	New	+$1.61M	0.21%	58
2018 Q3	–	Sell	-20,000	Closed	-$3.4M	–	129
2018 Q2	$3.4M	Buy	+20,000	New	+$3.1M	0.47%	68
2018 Q1	–	Sell	-85,823	Closed	-$12.9M	–	145
2017 Q4	$12.9M	Buy	85,823 +65,000	+312%	+$9.62M	1.51%	14
2017 Q3	$3.17M	Buy	+20,823	New	+$3.13M	0.45%	58
2017 Q1	–	Sell	-45,000	Closed	-$3.31M	–	126
2016 Q4	$3.31M	Buy	+45,000	New	+$3.66M	0.84%	35
2016 Q3	–	Sell	-57,600	Closed	-$4.96M	–	120
2016 Q2	$4.96M	Buy	+57,600	New	+$4.98M	1.29%	18
2016 Q1	–	Sell	-48,400	Closed	-$6.09M	–	119
2015 Q4	$6.09M	Buy	48,400 +8,400	+21%	+$1.01M	0.89%	16
2015 Q3	$4.17M	Buy	+40,000	New	+$5.14M	0.53%	36
2015 Q1	–	Sell	-30,000	Closed	-$3.56M	–	166
2014 Q4	$3.56M	Sell	30,000 -120,000	-80%	-$13.5M	0.61%	52
2014 Q3	$16.8M	Buy	+150,000	New	+$14.3M	2.08%	15
2014 Q2	–	Sell	-20,000	Closed	-$1.4M	–	126
2014 Q1	$1.41M	Buy	+20,000	New	+$1.58M	0.32%	63

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Sphera Funds Management's VRTX Position: Q1 2022 in Review

Sphera Funds Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2022, closing a stake of 4,411 shares — an estimated $969K sold.

Sphera Funds Management first reported a position in VRTX in Q1 2014 and held it in 13 quarters. The position peaked at $16.8M in Q3 2014. 1,073 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

Sphera Funds Management reported no remaining Vertex Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Sphera Funds Management sold 4,411 Vertex Pharmaceuticals shares in Q1 2022, an estimated $969K.
Sphera Funds Management first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 13 quarters.
Sphera Funds Management's Vertex Pharmaceuticals position peaked at $16.8M in Q3 2014.
1,073 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on Sphera Funds Management's 13F filing for Q1 2022, filed 16 May 2022.